Amicus is pioneering next-generation oral therapies for the management of human genetic diseases.
Private
Cranbury, NJ
BiPar is developing a potential new class of tumor-selective drugs designed to meet the unmet needs of cancer patients.
Private
Brisbane, CA
Cell Pathways is a development-stage pharmaceutical company focused on novel medications to treat and prevent cancer and certain autoimmune diseases.
Public. Acquired by OSI Pharmaceuticals
Horsham, PA
Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.
Public (CNTO)
Malvern, PA
Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and life–threatening infections.
Acquired by Forest Labs (FRX)
Alameda, CA
Chimerix develops orally-available, antiviral therapeutics for a broad range of viral diseases.
Private
Durham, NC
CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals to provide a renewable and previously untapped source of novel drug candidates.
Public (CRXX)
Boston, MA
Eon Lab is a drug manufacturer that develops, manufactures, and markets a broad range of generic pharmaceutical products.
Public. Acquired by Novaritis (NVS)
Lauralton, NY
Esperion is a biopharmaceutical company focused on the discovery and development of therapies for the treatment of cardiovascular disease.
Public. Acquired by Pfizer (PFE)
Ann Arbor, MI
Personalized medicine through population genomics and informatics.
Public. Acquired by Clinical Data (CLDA)
Newton, MA
Marinus develops novel drugs to treat serious neurological, psychiatric, and pain disorders such as epilepsy and bipolar disorder.
Private
Branford, CT
Matrix Pharmaceutical develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.
Public (MATX)
Menlo Park, CA
OraPharma is a specialty pharmaceutical company focused therapeutics for oral health.
Public. Acquired by Johnson & Johnson (JNJ)
Warminster, PA
Orthocon is a specialty pharmaceutical and medical device company offering a new approach to the management of postoperative pain.
Private
Colts Neck, NJ
Peninsula Pharmaceuticals is developing new antibiotic medications to treat life-threatening infections.
Acquired by Johnson & Johnson (JNJ)
Alameda, CA
Phylogix is an early-stage pharmaceutical company developing chemoprotectant compounds.
Private
Waltham, MA
Pintex is applying a structure-based drug design approach to create novel cancer therapeutics.
Private
Watertown, MA
Pozen is a pharmaceutical company developing therapeutic advancements for treatment of acute migraine.
Public (POZN)
Chapel Hill, NC
Praecis Pharmaceuticals is a biopharmaceutical company focused on Peptide-based therapeutics that have the potential to address unmet medical needs or improve existing therapies.
Public. Acquired by GlaxoSmithKline (GSK)
Cambridge, MA
Sopherion is a therapeutics platform company initially focused on cancer.
Private
Princeton, NJ
Spaltudaq harnesses the power of the human immune system to treat cancer and infectious diseases.
Private
Seattle, WA
Tobira develops novel drugs to help in the treatment of HIV and AIDS.
Private
San Diego, CA
VaxInnate is developing novel vaccines for pandemic and seasonal influenza.
Private
Cranbury, NJ
© 2008 Canaan Partners